These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22831824)

  • 1. Compounded bioidentical menopausal hormone therapy.
    ;
    Fertil Steril; 2012 Aug; 98(2):308-12. PubMed ID: 22831824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Committee opinion No. 532: compounded bioidentical menopausal hormone therapy.
    Committee on Gynecologic Practice and the American Society for Reproductive Medicine Practice Committee
    Obstet Gynecol; 2012 Aug; 120(2 Pt 1):411-5. PubMed ID: 22825109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounded or confused? Bioidentical hormones and menopausal health.
    Huntley AL
    Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
    Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the concerns about custom-compounded "bioidentical" hormone therapy?
    Pinkerton JV
    Menopause; 2014 Dec; 21(12):1298-300. PubMed ID: 25387347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioidentical hormone therapy: a review of the evidence.
    Cirigliano M
    J Womens Health (Larchmt); 2007 Jun; 16(5):600-31. PubMed ID: 17627398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
    Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
    J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioidentical hormone therapy: a panacea that lacks supportive evidence.
    Boothby LA; Doering PL
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):400-7. PubMed ID: 18660693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioidentical hormones for menopausal therapy.
    Sites CK
    Womens Health (Lond); 2008 Mar; 4(2):163-71. PubMed ID: 19072518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioidentical hormones for menopausal hormone therapy: variation on a theme.
    Fugh-Berman A; Bythrow J
    J Gen Intern Med; 2007 Jul; 22(7):1030-4. PubMed ID: 17549577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
    Thompson JJ; Ritenbaugh C; Nichter M
    BMC Womens Health; 2017 Oct; 17(1):97. PubMed ID: 28969624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
    Davis R; Batur P; Thacker HL
    J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
    Pinkerton JV; Santoro N
    Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.
    Moskowitz D
    Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center.
    Iftikhar S; Shuster LT; Johnson RE; Jenkins SM; Wahner-Roedler DL
    J Womens Health (Larchmt); 2011 Apr; 20(4):559-65. PubMed ID: 21486160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounded Bioidentical Hormones: Myths and Realities.
    Santoro N; Liss J
    Clin Obstet Gynecol; 2021 Dec; 64(4):793-802. PubMed ID: 34482337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.